Delta 9 Cannabis (TSXV:NINE) announced a non-binding letter of intent with Pharmasave to be a preferred supplier of medical cannabis.
As quoted in the press release:
Pharmasave is a member owned and governed cooperative of more than 650 independent community pharmacies across Canada. Pharmasave believes that pharmacists, as medication management experts, play an important role in helping to improve patient care. For more than a year, Pharmasave has been providing education and resources on medical cannabis to help Pharmasave pharmacists understand more about the current regulations and learn more about the possible uses, benefits and risks of medical cannabis. Pharmacists can provide advice on potential drug-to-drug interactions and the therapeutic value of treatment options to patients and allied health professionals to help them make educated and informed decisions about products and monitoring.
Following execution of the Letter of Intent, the two companies are jointly working to conclude definitive agreements for supply and distribution of Delta 9’s medical cannabis through Pharmasave pharmacists, pending changes to Canadian legislation that would allow such distribution.